Immunotherapy for post-transplant lymphoproliferative disease

被引:46
作者
Straathof, KCM [1 ]
Savoldo, B [1 ]
Heslop, HE [1 ]
Rooney, CM [1 ]
机构
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
关键词
Epstein-Barr virus; lymphoproliferative disease; transplantation; immunotherapy; cytotoxic T cells;
D O I
10.1046/j.1365-2141.2002.03594.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:728 / 740
页数:13
相关论文
共 99 条
  • [91] Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT
    van Esser, JWJ
    van der Holt, B
    Meijer, E
    Niesters, HGM
    Trenschel, R
    Thijsen, SFT
    van Loon, AM
    Frassoni, F
    Bacigalupo, A
    Schaefer, UW
    Osterhaus, ADME
    Gratama, JW
    Löwenberg, B
    Verdonck, LF
    Cornelissen, JJ
    [J]. BLOOD, 2001, 98 (04) : 972 - 978
  • [92] Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation
    van Esser, JWJ
    Niesters, HGM
    Thijsen, SFT
    Meijer, E
    Osterhaus, ADME
    Wolthers, KC
    Boucher, CAB
    Gratama, JW
    Budel, LM
    van der Holt, B
    van Loon, AM
    Löwenberg, B
    Verdonck, LF
    Cornelissen, JJ
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (03) : 814 - 821
  • [93] Wagner HJ, 2001, BLOOD, V98, p480A
  • [94] Patients at risk for development of posttransplant lymphoproliferative disorder: Plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction
    Wagner, HJ
    Wessel, M
    Jabs, W
    Smets, F
    Fischer, L
    Offner, G
    Bucsky, P
    [J]. TRANSPLANTATION, 2001, 72 (06) : 1012 - 1019
  • [95] Yang J, 2000, BLOOD, V96, P4055
  • [96] Application of the ELISPOT assay to the characterization of CD8+ responses to Epstein-Barr virus antigens
    Yang, J
    Lemas, VM
    Flinn, IW
    Krone, C
    Ambinder, RF
    [J]. BLOOD, 2000, 95 (01) : 241 - 248
  • [97] A RE-EXAMINATION OF THE EPSTEIN-BARR VIRUS CARRIER STATE IN HEALTHY SEROPOSITIVE INDIVIDUALS
    YAO, QY
    RICKINSON, AB
    EPSTEIN, MA
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1985, 35 (01) : 35 - 42
  • [98] Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases
    Zompi, S
    Tulliez, M
    Conti, F
    Leblond, V
    Gaulard, P
    Blanche, P
    Durand, F
    Ghandi, D
    Dreyfus, F
    Louvel, A
    Calmus, Y
    Bouscary, D
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 (03) : 521 - 527
  • [99] ZUTTER MM, 1988, BLOOD, V72, P520